Stifel Financial Corp Arcutis Biotherapeutics, Inc. Transaction History

Stifel Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$17.82 - $31.73 $423,189 - $753,524	-23,748 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$23.44 - $32.28 $68,468 - $94,289	2,921 Added 14.03%	23,748 $696,000
Q2 2020 Aug 14, 2020	BUY	$24.48 - $36.56 $21,811 - $32,574	891 Added 4.47%	20,827 $630,000
Q1 2020 May 14, 2020	BUY	$18.5 - $36.9 $368,816 - $735,638	19,936 New	19,936 $594,000

218

129M

2.02M

202K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $784M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.